Literature DB >> 2287586

Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). An immunomorphometric study on trephine biopsies.

J Thiele1, S Wagner, H P Bertsch, S Wienhold, R Fischer, D Dienemann, H Stein, R Zankovich.   

Abstract

An immunomorphometric study was performed on bone marrow biopsies from 40 patients with primary osteomyelofibrosis--OMF, (agnogenic myeloid metaplasia) by employment of a monoclonal antibody against glycoprotein IIIa (Y2/51) to determine the number of pro-megakaryoblasts. Specimens from 15 individuals without any hematological disorder served as controls. With reference to the pertinent literature on megakaryocyte precursors and following a pilot study on corresponding smears, in tissue sections pro-megakaryoblasts were characterized by a size of 42.1 +/- 2.6 microns 2 (diameter 7.5 +/- 0.3 microns). In comparison with controls, in OMF no relevant increase in the number of pro-megakaryoblasts per square and cubic millimeter bone marrow was evaluable. The relative frequency of these precursors was significantly reduced due to an increase in the total amount of conspicuously large and abnormal megakaryocytes. Statistical analysis failed to reveal any correlations between counts for pro-megakaryoblasts or the total number of Y2/51--positive megakaryocytic elements with the density of argyrophilic fibers (determined by morphometry) or the platelet values. Our findings imply that in OMF the marked increase in circulating progenitor cells of the megakaryocyte lineage may be generated by extramedullary, probably splenic hematopoiesis. Moreover, the evolution of medullary fibrosis is thought to be associated with the striking predominance of large atypical, possibly overaged and hyperpolyploid megakaryocytes and not with an increase in precursor cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2287586     DOI: 10.1016/S0344-0338(11)80222-0

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

1.  [Pulmonary hypertension in chronic myeloproliferative disorders].

Authors:  B M Einsfelder; K-M Müller
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

2.  Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders.

Authors:  A Matolcsy; R Nádor; E Wéber; T Kónya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.